Drug search by name

Obinutuzumab Intravenous and Cardiopulmonary disease

Result of checking the interaction of drug Obinutuzumab Intravenous and disease Cardiopulmonary disease for safety when used together.

Check result:

Obinutuzumab Intravenous <> Cardiopulmonary disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Patients with a prior history of cardiac or pulmonary disease should be closely monitored during and after the infusion of anti-CD20 antibodies as they can increase the risk of presenting a severe and life-threatening infusion reaction. Therapy with these agents should be permanently discontinued in patients presenting any Grade 4 infusion reactions and for those presenting Grade 3, interrupt therapy and institute treatment according to clinical guidelines. The rate of infusion should be reduced for those patients presenting Grade 1, or 2 reactions.

Obinutuzumab Intravenous

Generic Name: obinutuzumab

Brand Name: Gazyva

Synonyms: Obinutuzumab

What is Obinutuzumab Intravenous?